Certified by Founder
Lodge
Electra Therapeutics
start up
United States
- South San Francisco, California
- 22/10/2025
- Series C
- $183,000,000
Electra Therapeutics is a clinical stage biotechnology company developing therapies that target signal regulatory proteins (SIRP) for the treatment of immunological diseases and cancer.
- Industry Biotechnology Research
- Website https://electra-therapeutics.com/
- LinkedIn https://www.linkedin.com/company/electra-tx/
Derapi | $7,000,000 | (Feb 4, 2026)
Mitra EV | $27,000,000 | (Feb 4, 2026)
enclaive | $4,849,418 | (Feb 4, 2026)
Graici | $7,500,000 | (Feb 4, 2026)
MaiaEdge | $20,000,000 | (Feb 4, 2026)
Arbor(US) | $6,300,000 | (Feb 4, 2026)
ecovia I bio | Undisclosed Amount | (Feb 4, 2026)
Prenosis | $20,000,000 | (Feb 3, 2026)
Linq | $20,000,000 | (Feb 3, 2026)
Breezy | $10,000,000 | (Feb 3, 2026)
JJG Machining Group | $30,000,000 | (Feb 3, 2026)